NO20075086L - Behandling av Parkinsons sykdom, obstruktiv sovn apne, demens med Lewy legemer, vaskulaer demens med ikke-imidazol alkylamin histamin H3-reseptor ligander - Google Patents

Behandling av Parkinsons sykdom, obstruktiv sovn apne, demens med Lewy legemer, vaskulaer demens med ikke-imidazol alkylamin histamin H3-reseptor ligander

Info

Publication number
NO20075086L
NO20075086L NO20075086A NO20075086A NO20075086L NO 20075086 L NO20075086 L NO 20075086L NO 20075086 A NO20075086 A NO 20075086A NO 20075086 A NO20075086 A NO 20075086A NO 20075086 L NO20075086 L NO 20075086L
Authority
NO
Norway
Prior art keywords
dementia
parkinson
disease
sleep apnea
obstructive sleep
Prior art date
Application number
NO20075086A
Other languages
English (en)
Other versions
NO343603B1 (no
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35169680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075086(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of NO20075086L publication Critical patent/NO20075086L/no
Publication of NO343603B1 publication Critical patent/NO343603B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en ny behandlingsmetode av Parkinson's sykdom, obstruktiv søvnapné, narkolepsi, demens med Lewy bodies, vaskulær demens med ikke-imidazol alkylaminderivater som utgjør antagonister av H3-reseptorer av histamin.
NO20075086A 2005-04-01 2007-10-09 Forbindelse for anvendelse for behandling av søvnighet på dagtid assosiert med Parkinsons sykdom eller obstruktiv søvnapné, samt kombinasjon omfattende forbindelsen med et anti-parkinson medikament. NO343603B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05290727A EP1707203A1 (en) 2005-04-01 2005-04-01 Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
US66861805P 2005-04-06 2005-04-06
PCT/IB2006/000739 WO2006103546A2 (en) 2005-04-01 2006-03-30 Treatment of parkinson's disease, obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine h3-receptor ligands

Publications (2)

Publication Number Publication Date
NO20075086L true NO20075086L (no) 2007-12-27
NO343603B1 NO343603B1 (no) 2019-04-08

Family

ID=35169680

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075086A NO343603B1 (no) 2005-04-01 2007-10-09 Forbindelse for anvendelse for behandling av søvnighet på dagtid assosiert med Parkinsons sykdom eller obstruktiv søvnapné, samt kombinasjon omfattende forbindelsen med et anti-parkinson medikament.

Country Status (27)

Country Link
US (1) US8486947B2 (no)
EP (2) EP1707203A1 (no)
JP (3) JP5546761B2 (no)
KR (1) KR101308527B1 (no)
CN (1) CN101171009B (no)
AU (1) AU2006228413C1 (no)
BR (1) BRPI0612216B1 (no)
CA (1) CA2603656C (no)
CY (1) CY1114636T1 (no)
DK (1) DK1863487T4 (no)
EA (1) EA016007B1 (no)
ES (1) ES2426008T5 (no)
HR (1) HRP20130748T4 (no)
MA (1) MA29353B1 (no)
ME (1) ME01713B (no)
MX (1) MX2007012162A (no)
NO (1) NO343603B1 (no)
NZ (1) NZ561940A (no)
PL (1) PL1863487T5 (no)
PT (1) PT1863487E (no)
RS (1) RS52911B2 (no)
SG (1) SG147415A1 (no)
SI (1) SI1863487T2 (no)
TN (1) TNSN07365A1 (no)
UA (1) UA94902C2 (no)
WO (1) WO2006103546A2 (no)
ZA (1) ZA200708086B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808773A (en) 2006-06-23 2008-02-16 Abbott Lab Cyclopropyl amine derivatives
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
FR2903904A1 (fr) * 2006-07-21 2008-01-25 Bioprojet Soc Civ Ile Association de modafinil et d'un antagoniste ou agoniste inverse du recepteur h3
PL2069312T3 (pl) 2006-07-25 2013-03-29 Cephalon Inc Pochodne pirydazynonu
US8153813B2 (en) 2007-12-20 2012-04-10 Abbott Laboratories Benzothiazole and benzooxazole derivatives and methods of use
JP5524083B2 (ja) 2008-01-30 2014-06-18 セファロン、インク． ヒスタミン−３（ｈ３）受容体リガンドとしての置換スピロ環状ピペリジン誘導体
FR2932479A1 (fr) * 2008-06-13 2009-12-18 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
US8853390B2 (en) 2010-09-16 2014-10-07 Abbvie Inc. Processes for preparing 1,2-substituted cyclopropyl derivatives
US9181275B2 (en) 2011-08-11 2015-11-10 Abbvie Inc. Mercaptoamidine derivatives and methods of use
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
BR112015007641A8 (pt) * 2012-10-05 2018-04-03 Vtv Therapeutics Llc Tratamento da doença de alzheimer branda e moderada
EP3391886A1 (en) 2017-04-19 2018-10-24 Novartis AG The use of a h3r inverse agonist for the treatment of shift work disorder
US20200281522A1 (en) 2019-03-06 2020-09-10 Medtronic Xomed, LLC System and method for improved obstructive sleep apnea diagnostic for implantable devices
EP4248969A1 (en) 2022-03-23 2023-09-27 Bioprojet Use of pitolisant for treating severe fatigue

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5815945A (ja) * 1981-07-21 1983-01-29 Teikoku Hormone Mfg Co Ltd 新規なフエノキシアルキルアミン誘導体
FR2579596B1 (fr) 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
FR2671083B1 (fr) 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
DE69222757T2 (de) 1991-02-27 1998-02-12 Seed Capital Investments Imidazol-derivate mit antagonistischer aktivität auf den histamin-h3-receptor
JPH07121939B2 (ja) 1991-12-18 1995-12-25 シェリング・コーポレーション 窒素含有４または５員複素環で置換されたイミダゾリルまたはイミダゾイルアルキル化合物
DE69212164T2 (de) 1991-12-18 1996-12-05 Schering Corp Imidolylalkyl-derivate substituiert mit einem stickstoffenthaltende-6 gliedrigen ring
FR2686084B1 (fr) 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
US5486526A (en) * 1992-04-01 1996-01-23 The University Of Toledo Histamine H3 -receptor antagonists and therapeutic uses thereof
US5380858A (en) 1992-04-01 1995-01-10 The University Of Toledo Process for the preparation of intermediates useful for the synthesis of histamine receptor antagonists
US5639775A (en) 1992-04-01 1997-06-17 The University Of Toledo 4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3 -receptor antagonists and therapeutic uses thereof
EP0680960A4 (en) 1993-01-25 1997-05-14 Green Cross Corp IMIDAZOLE CONNECTION.
JP3522790B2 (ja) 1993-06-08 2004-04-26 花王株式会社 Ｈ３−レセプター刺激薬
WO1995006037A1 (en) 1993-08-27 1995-03-02 Vrije Universiteit New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor
GB9319534D0 (en) * 1993-09-22 1993-11-10 Boots Co Plc Therapeutic agents
WO1995014007A1 (en) 1993-11-15 1995-05-26 Schering Corporation Phenyl-alkyl imidazoles as h3-receptor antagonists
GB9411045D0 (en) * 1994-06-02 1994-07-20 Smithkline Beecham Plc Compounds and use
FR2732017B1 (fr) 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
US5652258A (en) 1995-05-30 1997-07-29 Gliatech, Inc. 2-(4-imidazoyl) cyclopropyl derivatives
DE69619381T2 (de) 1995-05-30 2002-11-21 Gliatech Inc 1h-4(5)substituierte imidazolderivate
PT841923E (pt) 1995-06-07 2003-01-31 Gliatech Inc Derivados de 1h.imidazole 4(5)-substituido
HUP9901190A3 (en) 1996-02-09 2002-05-28 Black James Foundation Sulfonamide derivatives of imidazole, process for producing them and pharmaceutical compositions containing them
JP3925579B2 (ja) * 1998-02-03 2007-06-06 日本精工株式会社 潤滑剤供給体、並びに前記潤滑剤供給体を備える転がり軸受、リニアガイド装置及びボールねじ装置
EP0982300A3 (en) * 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
US6136559A (en) * 1998-10-07 2000-10-24 Ortho Pharmaceutical Corporation DNA encoding as human histamine receptor of the H3 subtype
PL196773B1 (pl) * 1999-06-11 2008-01-31 Toyama Chemical Co Ltd Pochodna N-alkiloksyalkilo-N,N-dialkiloaminy lub jej sole oraz środek zawierający ten związek stosowany do leczenia chorób neurodegeneratywnych
GB9924941D0 (en) * 1999-10-22 1999-12-22 Univ Manchester Treatment of dyskinesia
US6620839B2 (en) * 2000-07-13 2003-09-16 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
JP5279161B2 (ja) * 2000-08-08 2013-09-04 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 非イミダゾールアリールオキシアルキルアミン
CA2419073A1 (en) * 2000-08-17 2002-02-21 Gliatech, Inc. Novel alicyclic imidazoles as h3 agents
EP1320364A1 (en) * 2000-08-21 2003-06-25 Gliatech, Inc. The use of histamine h3-receptor inverse agonists for the control of appetite and treatment of obesity
CA2442326C (en) * 2001-03-29 2012-05-22 Ortho-Mcneil Pharmaceutical, Inc. Imidazolyl derivatives useful as histamine h3 receptor ligands
EP1451225A1 (en) * 2001-11-15 2004-09-01 Ortho-McNeil Pharmaceutical, Inc. Agonists of recombinant human histamine h3 receptor
EP1451167B1 (en) * 2001-12-10 2006-03-08 Ortho-McNeil Pharmaceutical, Inc. Phenylalkynes
CA2504272A1 (en) * 2002-10-23 2004-05-06 Janssen Pharmaceutica, N.V. Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
CN1812981A (zh) * 2003-06-27 2006-08-02 万有制药株式会社 杂芳氧基含氮饱和杂环衍生物
FR2856596B1 (fr) * 2003-06-27 2007-04-27 Bioprojet Soc Civ Nouvelle association medicamenteuse psychiatrique et utilisation d'une antagoniste ou agoniste inverse du recepteur h3 de l'histamine pour preparer un medicament prevenant des effets indesirables de psychotropes.
SE0302116D0 (sv) * 2003-07-21 2003-07-21 Astrazeneca Ab Novel compounds
ATE547404T1 (de) * 2003-09-22 2012-03-15 Msd Kk Piperidinderivate

Also Published As

Publication number Publication date
MA29353B1 (fr) 2008-03-03
ES2426008T5 (es) 2020-03-20
KR20080002904A (ko) 2008-01-04
DK1863487T3 (da) 2013-08-12
NZ561940A (en) 2010-06-25
NO343603B1 (no) 2019-04-08
BRPI0612216B1 (pt) 2022-04-19
JP5546761B2 (ja) 2014-07-09
DK1863487T4 (da) 2019-10-14
JP2016106142A (ja) 2016-06-16
WO2006103546A2 (en) 2006-10-05
JP2008534572A (ja) 2008-08-28
WO2006103546A3 (en) 2007-03-01
EA200702135A1 (ru) 2008-04-28
SI1863487T1 (sl) 2013-09-30
RS52911B2 (sr) 2019-11-29
SG147415A1 (en) 2008-11-28
KR101308527B1 (ko) 2013-09-17
ES2426008T3 (es) 2013-10-18
HRP20130748T4 (hr) 2019-11-15
CA2603656A1 (en) 2006-10-05
EP1863487B1 (en) 2013-05-29
CY1114636T1 (el) 2016-10-05
MX2007012162A (es) 2007-11-22
AU2006228413B2 (en) 2011-09-15
EP1707203A1 (en) 2006-10-04
PT1863487E (pt) 2013-08-29
BRPI0612216A2 (pt) 2010-10-26
HRP20130748T1 (en) 2013-10-11
AU2006228413C1 (en) 2012-02-02
ME01713B (me) 2014-09-20
EP1863487A2 (en) 2007-12-12
PL1863487T5 (pl) 2021-08-09
RS52911B (en) 2014-02-28
EA016007B1 (ru) 2012-01-30
US20090318433A1 (en) 2009-12-24
US8486947B2 (en) 2013-07-16
UA94902C2 (ru) 2011-06-25
CN101171009B (zh) 2012-11-07
JP5955872B2 (ja) 2016-07-20
TNSN07365A1 (fr) 2008-12-31
PL1863487T3 (pl) 2014-10-31
AU2006228413A1 (en) 2006-10-05
SI1863487T2 (sl) 2019-11-29
ZA200708086B (en) 2008-10-29
EP1863487B2 (en) 2019-07-17
CN101171009A (zh) 2008-04-30
JP2014062126A (ja) 2014-04-10
CA2603656C (en) 2015-06-16

Similar Documents

Publication Publication Date Title
NO20075086L (no) Behandling av Parkinsons sykdom, obstruktiv sovn apne, demens med Lewy legemer, vaskulaer demens med ikke-imidazol alkylamin histamin H3-reseptor ligander
ATE435862T1 (de) Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
NO20072965L (no) Potentiatorer av glutamatreceptorer
CY1109599T1 (el) Κρυσταλλικες μορφες υδροχλωρικης (r)-8-χλωρο-1-μεθυλο-2,3,4,5-τετραϋδρο-1η-3-βενζαζεπινης
MX2009004900A (es) Arilamidas sustituidas por tiazol u oxazol.
EA200970583A1 (ru) Способ получения пиперазиниловых и диазепаниловых производных бензамида
MA28635B1 (fr) Methode de production de derives de 1, 4-diphenylazetidinone
MX2010006230A (es) Derivados de arilamida substituidos con triazol y su uso como antagonistas de receptor purinergico p2x3 y/o p2x2/3.
DE602006010540D1 (de) (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl)-amine mit aktivität am 5-ht-rezeptor
EA200701984A1 (ru) Конденсированные тиазольные производные, обладающие сродством к гистаминовому h3 рецептору
MX2011008336A (es) Derivados de dihidroquinolinona.
PT2221298E (pt) Derivados de fenilpirazole
NO20050885D0 (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
DK1945206T3 (da) Indolderivater som histamin 3-receptorinhibitorer til behandling af kognitive forstyrrelser og søvnforstyrrelser, obesitas og andre CNS-forstyrrelser
IS8388A (is) Blandan af serótónín endurupptökuhindra og histamín 3 viðtaka mótlyfi, öflugum verka eða hlutaverka
TW200519117A (en) Crystal of sufoxide derivatives -HC1
ITTO20040024A1 (it) Macchina per la produzione di fascicoli cuciti
SE0303488D0 (sv) New use 1X
IN2015DN02599A (no)
FI20050586A0 (fi) Menetelmä N-[4-(4-fluorofenyyli)-5-formyyli-6-isopropyylipyrimidiini-2-yyli]-N-metyylimetaanisulfonamidin valmistamiseksi